This international conference on "Globalisation and Open Innovation" examined trends in globalisation and "open" models for innovation in firms as well as implications for policy making.
Companies can boost their stock market valuations and lower their cost of capital through improved reporting of intellectual assets and value creation strategies that overcome the limits of accounting standards, according to a report by the OECD.
English, , 2,675kb
This article shows the possible opportunities and risks of nanotechnologies today.
This workshop provided a forum for exchanges of experience and mutual learning on best practices in some OECD countries and the current S&T indicator system in China.
This document provides information on current/planned activities related to the safety of manufactured nanomaterials in OECD countries. Information was provided as written reports by delegations who participated in the 1st Meeting of OECD's Working Party on Manufactured Nanomaterials.
La Suisse doit encore augmenter sa performance en innovation si elle souhaite accélérer sa croissance économique et préserver son niveau de vie exceptionnel dans un contexte de mondialisation accrue. Cet examen propose des réformes susceptibles de l’aider à relever ce défi.
Trouvez en un clic TOUTES les publications et études du Programme de l'OCDE sur l'avenir en anglais et en français.
Proceedings of an international workshop to assess the causes behind the low participation of women in scientific careers, especially at senior levels, and to identify good practice policies to attract, recruit and retain women in scientific careers in public and private research.
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
The main objectives of the workshop were: i) to discuss the history and evolution of the conceptual framework for the evaluation of transgenic plant products in the environment and OECD’s role in the development of that framework; ii) to discuss the current contribution of OECD’s Working Group for the Harmonization of Regulatory Oversight in Biotechnology to risk/ safety assessment practice; and iii) to discuss current risk assessment